CN107519142A - 一种盐酸环苯扎林舌下片及其制备方法 - Google Patents
一种盐酸环苯扎林舌下片及其制备方法 Download PDFInfo
- Publication number
- CN107519142A CN107519142A CN201710736021.3A CN201710736021A CN107519142A CN 107519142 A CN107519142 A CN 107519142A CN 201710736021 A CN201710736021 A CN 201710736021A CN 107519142 A CN107519142 A CN 107519142A
- Authority
- CN
- China
- Prior art keywords
- cyclobenzaprine hydrochloride
- sublingual tablet
- diluent
- disintegrant
- cyclobenzaprine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
时间(月) | 性状 | 有关物质(%) | 含量(%) |
0 | 白色 | 0.17 | 100.02 |
1 | 白色 | 0.22 | 100.12 |
2 | 白色 | 0.41 | 100.41 |
3 | 白色 | 0.50 | 100.14 |
6 | 白色 | 0.56 | 100.11 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710736021.3A CN107519142B (zh) | 2017-08-24 | 2017-08-24 | 一种盐酸环苯扎林舌下片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710736021.3A CN107519142B (zh) | 2017-08-24 | 2017-08-24 | 一种盐酸环苯扎林舌下片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107519142A true CN107519142A (zh) | 2017-12-29 |
CN107519142B CN107519142B (zh) | 2021-02-26 |
Family
ID=60682090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710736021.3A Active CN107519142B (zh) | 2017-08-24 | 2017-08-24 | 一种盐酸环苯扎林舌下片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107519142B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104684550A (zh) * | 2012-06-15 | 2015-06-03 | 通尼克斯制药有限公司 | 用于跨粘膜吸收的组合物和方法 |
CN105395507A (zh) * | 2015-12-07 | 2016-03-16 | 青岛正大海尔制药有限公司 | 一种盐酸环苯扎林缓释片 |
-
2017
- 2017-08-24 CN CN201710736021.3A patent/CN107519142B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104684550A (zh) * | 2012-06-15 | 2015-06-03 | 通尼克斯制药有限公司 | 用于跨粘膜吸收的组合物和方法 |
CN105395507A (zh) * | 2015-12-07 | 2016-03-16 | 青岛正大海尔制药有限公司 | 一种盐酸环苯扎林缓释片 |
Also Published As
Publication number | Publication date |
---|---|
CN107519142B (zh) | 2021-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hays et al. | Psychometric properties of the medical outcomes study sleep measure | |
Kowalczyk et al. | Sex differences and hormonal influences on response to cold pressor pain in humans | |
Coffey et al. | A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment | |
Badia et al. | Validity and reliability of the Spanish version of the Psychological General Well-Being Index | |
Florea et al. | The effect of vortioxetine on health-related quality of life in patients with major depressive disorder | |
Bao et al. | Preliminary optimization of a Chinese herbal medicine formula based on the neuroprotective effects in a rat model of rotenone-induced Parkinson’s disease | |
Liu et al. | A Meta‐Analysis of the Effects of Tai Chi on Glucose and Lipid Metabolism in Middle‐Aged and Elderly Diabetic Patients: Evidence from Randomized Controlled Trials | |
CN107519142A (zh) | 一种盐酸环苯扎林舌下片及其制备方法 | |
Chapelsky et al. | A dose proportionality study of eprosartan in healthy male volunteers | |
Andia et al. | Gender differences in schizophrenia: A literature review | |
CN107496355A (zh) | 一种盐酸环苯扎林舌下喷雾剂及其制备方法 | |
Carneiro et al. | Different load intensity transition schemes to avoid plateau and no-response in lean body mass gain in postmenopausal women | |
Mishra et al. | A clinical study of Ashwagandha ghrita and Ashwagandha granules for its Brumhana and Balya effect | |
Fernández-Sánchez et al. | Effect of Acute Caffeine Intake on Fat Oxidation Rate during Fed-State Exercise: A Systematic Review and Meta-Analysis | |
Maxwell et al. | Allometric scaling of kidney function in green iguanas | |
Kwon et al. | Effects of the combination herbal extract on working memory and white matter integrity in healthy individuals with subjective memory complaints: A randomized, double-blind, placebo-controlled clinical trial | |
Phua et al. | Two instances of Chinese herbal medicine poisoning in Singapore | |
Li et al. | An evaluation of self-efficacy and satisfaction with the effectiveness of Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with chronic obstructive pulmonary disease | |
Yang | The Role and Mechanism of the Diabetes Control Based on the Association Rule Apriori Algorithm | |
Karmakar | Non communicable diseases risk factors among students of a government medical college in Kolkata | |
Zhai et al. | Bioequivalence study of amitriptyline hydrochloride tablets in healthy Chinese volunteers under fasting and fed conditions | |
Hayashi et al. | Oxatomide for stable asthma in adults and children | |
Goyal et al. | A clinical study on the role of Agnimanthadi compound in the management of Sthaulya (obesity) | |
Hart et al. | Social physique anxiety scale | |
Kong et al. | Randomized, multicenter clinical study of tratinterol hydrochloride tablets for the treatment of bronchial asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 266103 block L, Haier Industrial Park, Laoshan District, Qingdao City, Shandong Province Applicant after: CP PHARMACEUTICAL (QINGDAO) Co.,Ltd. Address before: 266103 block L, Haier Industrial Park, Laoshan District, Qingdao City, Shandong Province Applicant before: Qingdao Zhengda Haier Pharmaceutical Co.,Ltd. Address after: No.3601 Tuanjie Road, Qingdao Economic and Technological Development Zone, Shandong Province 266426 Applicant after: CP PHARMACEUTICAL (QINGDAO) Co.,Ltd. Address before: 266103 block L, Haier Industrial Park, Laoshan District, Qingdao City, Shandong Province Applicant before: CP PHARMACEUTICAL (QINGDAO) Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |